117.10
前日終値:
$117.88
開ける:
$118.88
24時間の取引高:
102.65K
Relative Volume:
0.14
時価総額:
$28.26B
収益:
$3.30B
当期純損益:
$-501.07M
株価収益率:
-55.38
EPS:
-2.1146
ネットキャッシュフロー:
$1.03B
1週間 パフォーマンス:
-2.26%
1か月 パフォーマンス:
-0.11%
6か月 パフォーマンス:
+31.61%
1年 パフォーマンス:
+26.29%
Biontech Se Adr Stock (BNTX) Company Profile
BNTX を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
BNTX
Biontech Se Adr
|
117.11 | 28.26B | 3.30B | -501.07M | 1.03B | -2.1146 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
481.15 | 123.34B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
697.27 | 76.09B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
648.71 | 39.34B | 1.86B | -40.29M | -1.28B | -0.85 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
251.07 | 32.49B | 2.25B | -278.16M | -42.59M | -2.17 |
Biontech Se Adr Stock (BNTX) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-01-10 | 開始されました | Truist | Buy |
2024-12-11 | 開始されました | Wells Fargo | Overweight |
2024-12-02 | 繰り返されました | BMO Capital Markets | Outperform |
2024-11-19 | 開始されました | Berenberg | Buy |
2024-11-19 | アップグレード | Evercore ISI | In-line → Outperform |
2024-11-08 | アップグレード | Goldman | Neutral → Buy |
2024-09-24 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
2024-09-17 | アップグレード | Jefferies | Hold → Buy |
2024-09-16 | アップグレード | JP Morgan | Underweight → Neutral |
2024-08-07 | アップグレード | Deutsche Bank | Hold → Buy |
2024-08-02 | アップグレード | HSBC Securities | Hold → Buy |
2024-05-14 | 開始されました | Evercore ISI | In-line |
2024-02-23 | 開始されました | BMO Capital Markets | Outperform |
2024-01-05 | 開始されました | Oppenheimer | Perform |
2023-12-01 | ダウングレード | JP Morgan | Neutral → Underweight |
2023-10-16 | ダウングレード | HSBC Securities | Buy → Hold |
2023-07-14 | 開始されました | HSBC Securities | Buy |
2023-05-17 | アップグレード | Redburn | Neutral → Buy |
2022-12-15 | アップグレード | BofA Securities | Neutral → Buy |
2022-08-17 | 開始されました | Cowen | Market Perform |
2022-07-13 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
2022-07-06 | 再開されました | Canaccord Genuity | Buy |
2022-02-01 | アップグレード | Redburn | Sell → Neutral |
2021-12-16 | 開始されました | Morgan Stanley | Equal-Weight |
2021-11-10 | アップグレード | H.C. Wainwright | Neutral → Buy |
2021-10-22 | 開始されました | Deutsche Bank | Hold |
2021-10-07 | 開始されました | Jefferies | Hold |
2021-08-11 | アップグレード | Bryan Garnier | Neutral → Buy |
2021-07-19 | 再開されました | Wolfe Research | Outperform |
2021-06-16 | ダウングレード | Redburn | Neutral → Sell |
2021-05-18 | 開始されました | Goldman | Neutral |
2021-05-11 | ダウングレード | Bryan Garnier | Buy → Neutral |
2020-12-01 | ダウングレード | BofA Securities | Buy → Neutral |
2020-08-03 | 再開されました | Berenberg | Buy |
2020-07-21 | アップグレード | BofA Securities | Neutral → Buy |
2020-06-30 | ダウングレード | H.C. Wainwright | Buy → Neutral |
2020-05-19 | アップグレード | H.C. Wainwright | Neutral → Buy |
2020-04-28 | ダウングレード | BofA/Merrill | Buy → Neutral |
2020-03-18 | ダウングレード | JP Morgan | Overweight → Neutral |
2020-03-09 | 開始されました | H.C. Wainwright | Neutral |
2020-01-24 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
2020-01-22 | ダウングレード | UBS | Buy → Neutral |
2019-11-05 | 開始されました | Wolfe Research | Outperform |
2019-11-04 | 開始されました | Berenberg | Buy |
2019-11-04 | 開始されました | BofA/Merrill | Buy |
2019-11-04 | 開始されました | Canaccord Genuity | Buy |
2019-11-04 | 開始されました | JP Morgan | Overweight |
2019-11-04 | 開始されました | SVB Leerink | Outperform |
2019-11-04 | 開始されました | UBS | Buy |
すべてを表示
Biontech Se Adr (BNTX) 最新ニュース
Antibody-Drug Conjugates Market to Witness Rapid Growth Across 7MM During the Study Period (2020–2034) as New Innovations Drive Therapy Advancements | DelveInsight - GlobeNewswire Inc.
AASTOCKS Financial NewsBioNTech SE (BNTX) - AASTOCKS.com
BioNTech SEADR to Host Earnings Call - ACCESS Newswire
Are Medical Stocks Lagging Auna S.A. (AUNA) This Year? - MSN
What Makes BioNTech (BNTX) a New Buy Stock - Yahoo Finance UK
BioNTech SE ADR (BNTX) did well last session? - US Post News
Electronic Arts Posts Upbeat Earnings, Joins Mattel, Johnson Controls, Mueller Water Products And Other Big Stocks Moving Higher On Wednesday - Benzinga
Pfizer's Q4 Earnings Beat Estimates, Non-Covid Drugs Drive Sales - Barchart
Moderna and BioNTech shares fall after Senate committee vote on RFK Jr. - Investing.com
Hesai Group ADR (HSAI) shows promising results - US Post News
Will Non-COVID Drugs Drive PFE's Top Line in Q4 Earnings? - Yahoo Finance
Validea Benjamin Graham Strategy Daily Upgrade Report1/31/2025 - Nasdaq
BioNTech's SWOT analysis: oncology pipeline, cash boost stock outlook - Investing.com
Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace
Stocks To Watch: BioNTech ADR Sees Relative Strength Rating Rise To 84 - Investor's Business Daily
Wall Street Analysts Predict a 25.59% Upside in BioNTech (BNTX): Here's What You Should Know - MSN
Years-Old List of Alleged Pfizer COVID-19 Vaccine 'Side Effects' Is Misleading - Snopes.com
BioNTech Expands Cancer Drug Pipeline: Launches Key Lung Cancer Trials, Advances Immunotherapy Programs - StockTitan
Why BioNTech (BNTX) Shares Are Volatile TodayBioNTech (NASDAQ:BNTX) - Benzinga
BioNTech SE ADR falls Wednesday, underperforms market - MarketWatch
Vaccine Stocks Jump After CDC Reports First US Bird-Flu Death - Yahoo Finance
BioNTech SE ADR rises Tuesday, outperforms market - MarketWatch
Moderna, BioNTech, Novavax Surge After CDC Reports Two-Week Covid Spike - Investor's Business Daily
BioNTech SE ADR rises Monday, outperforms market - MarketWatch
BNTX: 3 Genomic Stocks Unlocking the Secrets of DNA - StockNews.com
BioNTech SE ADR rises Friday, still underperforms market - MarketWatch
BioNTech SE ADR rises Thursday, outperforms market - MarketWatch
Russia develops mRNA cancer vaccine for citizens, skepticism lingers - Mugglehead
BioNTech SE ADR falls Monday, underperforms market - MarketWatch
BioNTech SE ADR rises Friday, outperforms market - MarketWatch
BioNTech SE ADR falls Thursday, underperforms market - MarketWatch
BioNTech SE ADR rises Tuesday, still underperforms market - MarketWatch
BioNTech SE ADR rises Monday, still underperforms market - MarketWatch
Stocks Generating Improved Relative Strength: BioNTech ADR - Investor's Business Daily
BioNTech's SWOT analysis: mRNA pioneer's stock faces oncology pipeline test - Investing.com
BioNTech SE ADR falls Friday, underperforms market - MarketWatch
BioNTech SE ADR rises Wednesday, outperforms market - MarketWatch
BioNTech SE ADR falls Tuesday, underperforms market - MarketWatch
Biontech Se Adr (BNTX) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):